Imaging the neural correlates of cholinergic and behaviour driven rehabilitation in patients with Wernickes aphasia: a double-blinded, cross-over, randomised controlled trial.

Trial Profile

Imaging the neural correlates of cholinergic and behaviour driven rehabilitation in patients with Wernickes aphasia: a double-blinded, cross-over, randomised controlled trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Sep 2017

At a glance

  • Drugs Donepezil (Primary)
  • Indications Aphasia
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Jul 2017 Primary endpoint has been met (Correlation between treatment type and improvements on conventional language rating scales acquired in face-to-face interviews with patients. Primary outcome measure, the language modality mean score from the Comprehensive Aphasia Test (CAT). This is a transformed T score with good: test-retest stability, inter-rater reliability and predictive validity.), according to results published in the Journal of Neurology, Neurosurgery and Psychiatry.
    • 14 Jun 2012 Inclusion and exclusion criteria amended as reported by United Kingdom Clinical Research Network record.
    • 01 Apr 2009 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top